ProfileGDS4718 / 220724_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 77% 70% 21% 81% 74% 18% 24% 84% 81% 81% 88% 69% 56% 24% 69% 67% 89% 16% 68% 16% 85% 83% 86% 84% 68% 49% 84% 12% 82% 33% 30% 45% 64% 84% 21% 29% 26% 76% 73% 2% 84% 28% 29% 62% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.5159677
GSM549102patient 115, normal, homogenized [OPG study]6.8659370
GSM549104patient 119, normal, homogenized [OPG study]4.1608521
GSM549108patient 138, normal, homogenized [OPG study]7.8540781
GSM549119patient 077, normal, homogenized [OPG study]7.1770174
GSM549133patient 032, cancer, homogenized [OPG study]4.0156118
GSM549139patient 042, cancer, homogenized [OPG study]4.2718624
GSM549099patient 107, normal, homogenized [OPG study]8.3000684
GSM549109patient 139, normal, homogenized [OPG study]7.8714781
GSM549110patient 046, normal, homogenized [OPG study]7.9691181
GSM549114patient 063, normal, homogenized [OPG study]8.9697688
GSM549122patient 082, normal, homogenized [OPG study]6.836869
GSM549134patient 033, cancer, homogenized [OPG study]5.8539756
GSM549136patient 036, cancer, homogenized [OPG study]4.2412524
GSM549140patient 044, cancer, homogenized [OPG study]6.8135869
GSM549111patient 047, normal, homogenized [OPG study]6.6772867
GSM549113patient 057, normal, homogenized [OPG study]9.2242389
GSM549132patient 031, cancer, homogenized [OPG study]3.982316
GSM549137patient 038, cancer, homogenized [OPG study]6.7256468
GSM549142patient 047, cancer, homogenized [OPG study]4.0661716
GSM549100patient 110, normal, homogenized [OPG study]8.3971785
GSM549107patient 135, normal, homogenized [OPG study]8.2440583
GSM549115patient 068, normal, homogenized [OPG study]8.7714586
GSM549116patient 072, normal, homogenized [OPG study]8.4402684
GSM549120patient 078, normal, homogenized [OPG study]6.7419368
GSM549131patient 030, cancer, homogenized [OPG study]5.4080549
GSM549118patient 074, normal, homogenized [OPG study]8.415584
GSM549129patient 027, cancer, homogenized [OPG study]3.8589512
GSM549123patient 088, normal, homogenized [OPG study]8.0295382
GSM549124patient 006, cancer, homogenized [OPG study]4.7250433
GSM549126patient 015, cancer, homogenized [OPG study]4.5119230
GSM549128patient 025, cancer, homogenized [OPG study]5.2036845
GSM549103patient 117, normal, homogenized [OPG study]6.378364
GSM549117patient 073, normal, homogenized [OPG study]8.3670384
GSM549138patient 041, cancer, homogenized [OPG study]4.1506521
GSM549141patient 045, cancer, homogenized [OPG study]4.4388329
GSM549130patient 028, cancer, homogenized [OPG study]4.3782126
GSM549101patient 111, normal, homogenized [OPG study]7.4515876
GSM549105patient 128, normal, homogenized [OPG study]7.1246373
GSM549106patient 134, normal, homogenized [OPG study]3.389472
GSM549112patient 048, normal, homogenized [OPG study]8.3889284
GSM549125patient 011, cancer, homogenized [OPG study]4.4707728
GSM549127patient 024, cancer, homogenized [OPG study]4.4684629
GSM549135patient 035, cancer, homogenized [OPG study]6.2579962